Skip to Content

OGT 918 100 (Zavesca 100 mg)

Generic Name: miglustat

Pill with imprint OGT 918 100 is White, Capsule-shape and has been identified as Zavesca 100 mg. It is supplied by Actelion Pharmaceuticals US Inc.

Zavesca is used in the treatment of gaucher disease and belongs to the drug class miscellaneous metabolic agents. Risk cannot be ruled out during pregnancy. Zavesca 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for OGT 918 100

Zavesca

Generic Name:
miglustat
Imprint:
OGT 918 100
Strength:
100 mg
Color:
White
Size:
14.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous metabolic agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Actelion Pharmaceuticals US Inc
Inactive Ingredients:
sodium starch glycolate type A potato
povidone k30
magnesium stearate
gelatin
titanium dioxide
ferrosoferric oxide
shellac
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide